The AFIAS COVID-19 Ab (in conjunction with AFIAS-1 analyzer) is a fluorescence Immunoassay intended for the qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in serum, plasma, venous whole blood or fingerstick capillary whole blood samples from individuals with current or prior COVID-19 infection. The AFIAS COVID-19 Ab is intended for use as an aid in identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

​

AFIAS-1 is an automated immunoassay analyzer that detect or measures the concentration of target analyte in a clinical sample loaded onto a self-contained test cartridge which is  then inserted in the analyzer to automatically complete further steps to display the test result.

AFIAS-1 uses a single channel, it is optimized for small and mid-sized hospitals (or clinics) testing up to 10 samples per hour. For some tests, such as TSH, CRP, PCT, and HbA1c, a quantitative test can be performed using a small sample 30uL of whole blood from a finger or heel using an applicable C-tip (capillary tip).

​

For information to enhance your AFIAS-1 experience or if you'd like more information on our all in one cartridge release schedule contact us here.